Howland Capital Management LLC Bristol Myers Squibb CO Transaction History

Howland Capital Management LLC

$2.26 Billion
Q3 2024

A detailed history of Howland Capital Management LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Howland Capital Management LLC holds 19,594 shares of BMY stock, worth $1.1 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

19,594

Previous 21,918 10.6%

Holding current value

$1.1 Million

Previous $910,000 11.32%

% of portfolio

0.04%

Previous 0.04%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$39.66 - $51.75 $92,169 - $120,267	-2,324 Reduced 10.6%	19,594 $1.01 Million
Q2 2024 Aug 12, 2024	SELL	$40.25 - $52.99 $121,192 - $159,552	-3,011 Reduced 12.08%	21,918 $910,000
Q1 2024 May 03, 2024	BUY	$47.98 - $54.4 $17,464 - $19,801	364 Added 1.48%	24,929 $1.35 Million
Q4 2023 Jan 23, 2024	SELL	$48.48 - $57.85 $36,311 - $43,329	-749 Reduced 2.96%	24,565 $1.26 Million
Q3 2023 Oct 17, 2023	SELL	$57.89 - $64.73 $10,883 - $12,169	-188 Reduced 0.74%	25,314 $1.47 Million
Q2 2023 Jul 28, 2023	SELL	$63.71 - $70.74 $3,185 - $3,536	-50 Reduced 0.2%	25,502 $1.63 Million
Q1 2023 May 05, 2023	SELL	$65.71 - $74.53 $33,512 - $38,010	-510 Reduced 1.96%	25,552 $1.77 Million
Q4 2022 Jan 30, 2023	BUY	$68.48 - $81.09 $59,920 - $70,953	875 Added 3.47%	26,062 $1.87 Million
Q3 2022 Oct 17, 2022	BUY	$0.13 - $76.84 $499 - $295,219	3,842 Added 18.0%	25,187 $1.79 Million
Q2 2022 Jul 22, 2022	BUY	$72.62 - $79.98 $705,140 - $776,605	9,710 Added 83.46%	21,345 $1.66 Million
Q1 2022 Apr 27, 2022	BUY	$61.48 - $73.72 $20,288 - $24,327	330 Added 2.92%	11,635 $850,000
Q4 2021 Jan 26, 2022	SELL	$53.63 - $62.52 $45,960 - $53,579	-857 Reduced 7.05%	11,305 $705,000
Q3 2021 Oct 25, 2021	SELL	$59.17 - $69.31 $23,668 - $27,724	-400 Reduced 3.18%	12,162 $720,000
Q2 2021 Jul 28, 2021	SELL	$61.91 - $67.42 $235,567 - $256,533	-3,805 Reduced 23.25%	12,562 $839,000
Q1 2021 Apr 28, 2021	SELL	$59.34 - $66.74 $55,186 - $62,068	-930 Reduced 5.38%	16,367 $1.03 Million
Q4 2020 Jan 26, 2021	SELL	$57.74 - $65.43 $56,642 - $64,186	-981 Reduced 5.37%	17,297 $1.07 Million
Q3 2020 Oct 26, 2020	SELL	$57.43 - $63.64 $28,427 - $31,501	-495 Reduced 2.64%	18,278 $1.1 Million
Q2 2020 Jul 15, 2020	SELL	$54.82 - $64.09 $97,579 - $114,080	-1,780 Reduced 8.66%	18,773 $1.1 Million
Q1 2020 Apr 13, 2020	SELL	$46.4 - $67.43 $5.92 Million - $8.6 Million	-127,566 Reduced 86.12%	20,553 $1.15 Million
Q4 2019 Jan 23, 2020	BUY	$49.21 - $64.19 $5.76 Million - $7.52 Million	117,144 Added 378.19%	148,119 $9.51 Million
Q3 2019 Oct 22, 2019	BUY	$42.77 - $50.71 $209,573 - $248,479	4,900 Added 18.79%	30,975 $1.57 Million
Q2 2019 Jul 17, 2019	SELL	$44.62 - $49.34 $249,336 - $275,711	-5,588 Reduced 17.65%	26,075 $1.18 Million
Q1 2019 Apr 22, 2019	SELL	$45.12 - $53.8 $54,369 - $64,829	-1,205 Reduced 3.67%	31,663 $1.51 Million
Q4 2018 Jan 23, 2019	SELL	$48.76 - $63.23 $916,785 - $1.19 Million	-18,802 Reduced 36.39%	32,868 $1.71 Million
Q3 2018 Oct 25, 2018	BUY	$55.19 - $62.25 $37,418 - $42,205	678 Added 1.33%	51,670 $3.21 Million
Q2 2018 Jul 23, 2018	BUY	$50.53 - $62.98 $32,339 - $40,307	640 Added 1.27%	50,992 $2.82 Million
Q1 2018 May 02, 2018	BUY	$59.92 - $68.98 $465,278 - $535,629	7,765 Added 18.23%	50,352 $3.19 Million
Q4 2017 Feb 01, 2018	SELL	$59.94 - $65.35 $6,893 - $7,515	-115 Reduced 0.27%	42,587 $2.61 Million
Q3 2017 Oct 30, 2017	BUY	$55.23 - $63.74 $2.36 Million - $2.72 Million	42,702	42,702 $2.72 Million

Others Institutions Holding BMY

# of Institutions

2,533

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $120B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Howland Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Howland Capital Management LLC with notifications on news.

Account

Howland Capital Management LLC Bristol Myers Squibb CO Transaction History